Division of Infectious Diseases and Immunology Research | NYU Langone Health

Skip to Main Content

Division of Infectious Diseases and Immunology Research

We focus on research to find new ways to prevent, diagnose, and treat infectious diseases.

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.

Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.

We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.

Core Faculty Investigators

Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies

Ramin Herati, MD
Assistant Professor, Department of Medicine

Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine

Vanessa N. Raabe, MD
Assistant Professor, Department of Medicine

Bo Shopsin, MD, PhD
Director, Molecular Epidemiology
Program Director, NYU Langone Molecular Outbreak Program
The Saul J. Farber Assistant Professor of Medicine, Department of Medicine
Assistant Professor, Department of Microbiology

Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine

Faculty Publications

Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.

Pediatric Osteoarticular Infections Caused by Mycobacteria Tuberculosis Complex: A 26-year Review of Cases in San Diego, CA

Drobish, Ian; Ramchandar, Nanda; Raabe, Vanessa; Pong, Alice; Bradley, John; Cannavino, Christopher

Pediatric infectious disease journal. 2021 Dec 30;

High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals

Tada, Takuya; Zhou, Hao; Dcosta, Belinda M; Samanovic, Marie I; Cornelius, Amber; Herati, Ramin S; Mulligan, Mark J; Landau, Nathaniel R

Cell reports. 2021 Dec 21; 110237

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Falsey, Ann R; Sobieszczyk, Magdalena E; Hirsch, Ian; Sproule, Stephanie; Robb, Merlin L; Corey, Lawrence; Neuzil, Kathleen M; Hahn, William; Hunt, Julie; Mulligan, Mark J; McEvoy, Charlene; DeJesus, Edwin; Hassman, Michael; Little, Susan J; Pahud, Barbara A; Durbin, Anna; Pickrell, Paul; Daar, Eric S; Bush, Larry; Solis, Joel; Carr, Quito Osuna; Oyedele, Temitope; Buchbinder, Susan; Cowden, Jessica; Vargas, Sergio L; Benavides, Alfredo Guerreros; Call, Robert; Keefer, Michael C; Kirkpatrick, Beth D; Pullman, John; Tong, Tina; Isaacs, Margaret Brewinski; Benkeser, David; Janes, Holly E; Nason, Martha C; Green, Justin A; Kelly, Elizabeth J; Maaske, Jill; Mueller, Nancy; Shoemaker, Kathryn; Takas, Therese; Marshall, Richard P; Pangalos, Menelas N; Villafana, Tonya; Gonzalez-Lopez, Antonio; [Eckhardt, Benjamin]

New England journal of medicine. 2021 Dec 16; 385:2348-2360

Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals

Samanovic, Marie I; Cornelius, Amber R; Gray-Gaillard, Sophie L; Allen, Joseph Richard; Karmacharya, Trishala; Wilson, Jimmy P; Wesley Hyman, Sara; Tuen, Michael; Koralov, Sergei B; Mulligan, Mark J; Sedaghat Herati, Ramin

Science translational medicine. 2021 Dec 07; eabi8961

Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community

Carmody, Ellie R; Zander, Devon; Klein, Elizabeth J; Mulligan, Mark J; Caplan, Arthur L

Journal of community health. 2021 Dec ; 46:1161-1169

First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19

Chen, Peter; Datta, Gourab; Grace Li, Ying; Chien, Jenny; Price, Karen; Chigutsa, Emmanuel; Brown-Augsburger, Patricia; Poorbaugh, Josh; Fill, Jeffrey; Benschop, Robert J; Rouphael, Nadine; Kay, Ariel; Mulligan, Mark J; Saxena, Amit; Fischer, William A; Dougan, Michael; Klekotka, Paul; Nirula, Ajay; Benson, Charles

Clinical pharmacology & therapeutics. 2021 12 ; 110:1467-1477

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Aponte-Melendez, Yesenia; Mateu-Gelabert, Pedro; Fong, Chunki; Eckhardt, Benjamin; Kapadia, Shashi; Marks, Kristen

Harm reduction journal. 2021 11 24; 18:118

Decreased production of epithelial-derived antimicrobial molecules at mucosal barriers during early life

Lokken-Toyli, Kristen L; de Steenhuijsen Piters, Wouter A A; Zangari, Tonia; Martel, Rachel; Kuipers, Kirsten; Shopsin, Bo; Loomis, Cynthia; Bogaert, Debby; Weiser, Jeffrey N

Mucosal immunology. 2021 Nov ; 14:1358-1368